tiprankstipranks
Trending News
More News >
Innovation Pharmaceuticals Inc (IPIX)
OTHER OTC:IPIX
US Market

Innovation Pharmaceuticals (IPIX) Income Statement

Compare
133 Followers

Innovation Pharmaceuticals Income Statement

Last quarter (Q1 2024), Innovation Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Innovation Pharmaceuticals's net income was $-880.00K. See Innovation Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 18.00K$ 0.00$ 423.00K$ 0.00
Gross Profit
$ -373.00K$ 18.00K$ -378.00K$ 423.00K$ -371.00K
Operating Expenses
$ 2.57M$ 6.94M$ 8.64M$ 5.06M$ 6.45M
Depreciation and Amortization
$ 373.00K$ 382.00K$ 378.00K$ 373.00K$ 371.00K
EBITDA
$ -2.74M$ -6.54M$ -8.64M$ -6.01M$ -6.11M
Operating Income
$ -3.11M$ -6.92M$ -9.02M$ -4.63M$ -6.45M
Other Income/Expenses
$ -229.00K$ -120.00K$ -4.86M$ -2.01M$ -2.23M
Pretax Income
$ -3.17M$ -7.04M$ -13.87M$ -6.65M$ -8.68M
Net Income
$ -3.17M$ -7.04M$ -13.87M$ -6.65M$ -9.07M
Per Share Metrics
Basic EPS
$ -0.01$ -0.01$ -0.04$ -0.03$ -0.05
Diluted EPS
$ -0.01$ -0.01$ -0.04$ -0.03$ -0.05
Weighted Average Shares Outstanding
505.77M 503.87M 386.16M 237.30M 178.23M
Weighted Average Shares Outstanding (Diluted)
505.77M 503.87M 386.16M 237.30M 178.23M
Currency in USD

Innovation Pharmaceuticals Earnings and Revenue History